Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Sales forecast by analysts have been recently revised upwards.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● Analyst opinion has improved significantly over the past four months.

● Consensus analysts have strongly revised their opinion of the company over the past 12 months.

● There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.


Weaknesses

● One of the major weak points of the company is its financial situation.

● With an expected P/E ratio at 39.69 and 37.62 respectively for both the current and next fiscal years, the company operates with high earnings multiples.

● The company's "enterprise value to sales" ratio is among the highest in the world.

● In relation to the value of its tangible assets, the company's valuation appears relatively high.

● The group usually releases earnings worse than estimated.